Portugal: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Portugal

The Portuguese market for other medicaments for therapeutic or prophylactic uses shrank to $X in 2022, with a decrease of X% against the previous year. In general, consumption continues to indicate a relatively flat trend pattern. As a result, consumption reached the peak level of $X. From 2020 to 2022, the growth of the market failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Portugal

In value terms, production of other medicaments for therapeutic or prophylactic uses stood at $X in 2022 estimated in export price. Overall, production, however, recorded strong growth. The pace of growth appeared the most rapid in 2018 when the production volume increased by X% against the previous year. Over the period under review, production of reached the peak level at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Portugal

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the fourth consecutive year after two years of decline. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2019 when exports increased by X% against the previous year. The exports peaked at X tons in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. Overall, exports saw significant growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

Germany (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Portugal, with a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Germany exceeded the volume sent to the second major destination, the United States (X tons), twofold. The third position in this ranking was held by Jordan (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume to Germany stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Jordan (X% per year).

In value terms, the United States ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Portugal, comprising X% of total exports. The second position in the ranking was held by Ireland ($X), with a X% share of total exports. It was followed by Germany, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ireland (X% per year) and Germany (X% per year).

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, rising by X% against the previous year. Overall, the export price posted a significant expansion. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was the United States ($X,667 per ton), while the average price for exports to Angola ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Portugal

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported into Portugal contracted to X tons, declining by X% on 2021. Overall, imports saw a mild reduction. The pace of growth appeared the most rapid in 2018 with an increase of X%. As a result, imports reached the peak of X tons. From 2019 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses shrank to $X in 2022. Over the period under review, imports, however, enjoyed resilient growth. The most prominent rate of growth was recorded in 2018 when imports increased by X%. Over the period under review, imports of attained the peak figure at $X in 2021, and then shrank in the following year.

Imports by Country

In 2022, Denmark (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Portugal, accounting for a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Denmark exceeded the figures recorded by the second-largest supplier, the Netherlands (X tons), twofold. Germany (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Denmark totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Germany (X% per year).

In value terms, Denmark ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Portugal, comprising X% of total imports. The second position in the ranking was held by Spain ($X), with a X% share of total imports. It was followed by the Netherlands, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Denmark amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Spain (X% per year) and the Netherlands (X% per year).

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, shrinking by X% against the previous year. Overall, the import price, however, continues to indicate a resilient increase. The growth pace was the most rapid in 2019 when the average import price increased by X% against the previous year. Over the period under review, average import prices reached the maximum at $X per ton in 2021, and then declined in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Malta ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :